APPLICATION
ANDA040823
TYPE
ANDA
ORIGINAL APPROVAL
2008-10-22
LATEST ACTION
2020-04-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
CARISOPRODOLPrescription
CARISOPRODOL 350MG · TABLET · ORAL
Approval history
2020-04-24Labeling · Supplement 2 · standardAP
2011-11-16Labeling · Supplement 1AP
2008-10-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.